drugset / Trial / NCT00696137
Long-term Extension Study of BEMA™ Fentanyl
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to provide continued access to BEMA Fentanyl for those subjects who previously participated in FEN-202 and who wish to continue using BEMA Fentanyl for the treatment of their breakthrough cancer pain.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-07
- Completion
- 2009-07